Lin Chen
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 2%
Papers in
-
- RNA modifications and cancer 30
- Circular RNAs in diseases 26
- Epigenetics and DNA Methylation 14
- RNA Interference and Gene Delivery 9
- Oncology 49
- Cancer Immunotherapy and Biomarkers 14
- Co-authors
- Yongheng Chen (3 shared papers)Na Liu (2 shared papers)Yun Li (2 shared papers)Huajun Zhang (1 shared paper)Yulia Merkher (1 shared paper)Sergey Leonov (1 shared paper)Alain Carpentier (7 shared papers)Jean‐Yves Delattre (3 shared papers)
- Journals
- Scientific Reports (11 papers)Frontiers in Immunology (8 papers)PLoS ONE (6 papers)Journal of Biological Chemistry (6 papers)Frontiers in Oncology (5 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Lin Chen
250 papers receiving 6.1k citations
Lin Chen's Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 999
- Oncology 1.1k
- Molecular Biology 3.0k
- Immunology 863
- Pulmonary and Respiratory Medicine 690
Countries citing papers authored by Lin Chen
This map shows the geographic impact of Lin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Chen more than expected).
Fields of papers citing papers by Lin Chen
This network shows the impact of papers produced by Lin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Chen. The network helps show where Lin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 267 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances in therapeutic strategies for triple-negative breast cancer Hit paper breakdown → | 2022 | 595 |
| 2 | 2017 | 327 | |
| 3 | 2009 | 311 | |
| 4 | Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. | 1999 | 166 |
| 5 | 2018 | 152 | |
| 6 | 2004 | 150 | |
| 7 | 2005 | 149 | |
| 8 | 2004 | 127 | |
| 9 | 2021 | 100 | |
| 10 | 2018 | 99 | |
| 11 | 2010 | 95 | |
| 12 | 2007 | 92 | |
| 13 | 2005 | 91 | |
| 14 | 2008 | 88 | |
| 15 | 2022 | 82 | |
| 16 | Increased expression of ceruloplasmin in the retina following photic injury. | 2003 | 77 |
| 17 | 2023 | 75 | |
| 18 | 2016 | 75 | |
| 19 | 1993 | 75 | |
| 20 | 1998 | 67 |
About Lin Chen
Lin Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Physiology, having authored 267 papers that have together received 6.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (30 papers), Circular RNAs in diseases (26 papers), Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (18 papers), Ferroptosis and cancer prognosis (15 papers), Cancer Immunotherapy and Biomarkers (14 papers), Epigenetics and DNA Methylation (14 papers) and RNA Interference and Gene Delivery (9 papers). The work is most often cited by research in Cancer Research (999 citations), Oncology (1.1k citations), Molecular Biology (3.0k citations), Immunology (863 citations) and Pulmonary and Respiratory Medicine (690 citations). Lin Chen has collaborated with scholars based in China, United States and France. Frequent co-authors include Yongheng Chen, Na Liu, Yun Li, Huajun Zhang, Yulia Merkher, Sergey Leonov, Alain Carpentier, Jean‐Yves Delattre, Anjana Rao and Chuan He. Their work appears in journals such as Scientific Reports, Frontiers in Immunology, PLoS ONE, Journal of Biological Chemistry and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.